Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease

References

• GodwinMRuhlandLCassonIPragmatic controlled clinical trials in primary care: the struggle between external and internal validityBMC Med Res Methodol200332814690550
   PubMedGoogle Scholar
• TraversJMarshSCaldwellBExternal validity of randomized controlled trials in COPDRespir Med200710161313132017113277
   PubMed Web of Science ®Google Scholar
• RothwellPMExternal validity of randomised controlled trials: “to whom do the results of this trial apply?”Lancet20053659453829315639683
   PubMed Web of Science ®Google Scholar
• PriceDHillyerEVvan der MolenTEfficacy versus effectiveness trials: informing guidelines for asthma managementCurr Opin Allergy Clin Immunol2013131505723242115
   PubMed Web of Science ®Google Scholar
• TraversJMarshSWilliamsMExternal validity of randomised controlled trials in asthma: to whom do the results of the trials apply?Thorax200762321922317105779
   PubMed Web of Science ®Google Scholar
• RocheNReddelHKAgustiARespiratory Effectiveness GroupIntegrating real-life studies in the global therapeutic research frameworkLancet Respir Med2013110e29e3024461762
   PubMed Web of Science ®Google Scholar
• ChatilaWMThomashowBMMinaiOACrinerGJMakeBJComorbidities in chronic obstructive pulmonary diseaseProc Am Thorac Soc20085454955518453370
   PubMedGoogle Scholar
• BarrRGCelliBRManninoDMComorbidities, patient knowledge, and disease management in a national sample of patients with COPDAm J Med2009122434835519332230
   PubMed Web of Science ®Google Scholar
• Carrasco-GarridoPde Miguel-DíezJRejas-GutierrezJCharacteristics of chronic obstructive pulmonary disease in Spain from a gender perspectiveBMC Pulm Med20099219121205
   PubMedGoogle Scholar
• FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
   PubMedGoogle Scholar
• SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: Role of comorbiditiesEur Respir J20062861245125717138679
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPBODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKEnrightPLFurbergCDMortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trialsBMJ2011342d321521672999
   PubMed Web of Science ®Google Scholar
• BeasleyRSinghSLokeYKEnrightPFurbergCDCall for worldwide withdrawal of tiotropium Respimat mist inhalerBMJ2012345e739023144209
   PubMed Web of Science ®Google Scholar
• JonesRCPriceDRyanDRespiratory Effectiveness GroupOpportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortLancet Respir Med20142426727624717623
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• ChanCKMaltaisFSigouinCHaddonJMFordGTA randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary diseaseCan Respir J200714846547218060091
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med2005143531732616144890
   PubMed Web of Science ®Google Scholar
• PowrieDJWilkinsonTMDonaldsonGCEffect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPDEur Respir J200730347247817504798
   PubMed Web of Science ®Google Scholar
• MoitaJBárbaraCCardosoJTiotropium improves FEV1 in patients with COPD irrespective of smoking statusPulm Pharmacol Ther200821114615117693107
   PubMed Web of Science ®Google Scholar
• CovelliHBhattacharyaSCassinoCConoscentiCKestenSAbsence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary diseasePharmacotherapy200525121708171816305289
   PubMed Web of Science ®Google Scholar
• CooperCBCelliBRJardimJRTreadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trialChest2013144249049723558890
   PubMed Web of Science ®Google Scholar
• BatemanEDTashkinDSiafakasNA one-year trial of tiotropium Respimat plus usual therapy in COPD patientsRespir Med2010104101460147220620037
   PubMed Web of Science ®Google Scholar
• AgustiACalverleyPMCelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigatorsCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol2006161637016039877
   PubMed Web of Science ®Google Scholar
• de Lucas-RamosPIzquierdo-AlonsoJLRodriguez-Gonzalez MoroJMCONSISTE study group. Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study)Int J Chron Obstruct Pulmon Dis2012767968623055717
   PubMed Web of Science ®Google Scholar
• FletcherMJUptonJTaylor-FishwickJCOPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age populationBMC Public Health20111161221806798
   PubMed Web of Science ®Google Scholar
• García-OlmosLAlberquillaAAyalaVComorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional studyBMC Fam Pract2013141123324308
   PubMed Web of Science ®Google Scholar
• HuiartLErnstPSuissaSCardiovascular morbidity and mortality in COPDChest200512842640264616236937
   PubMed Web of Science ®Google Scholar
• Jimenez-GarciaRde Miguel-DíezJRejas-GutierrezJHealth, treatment and health care resources consumption profile among Spanish adults with diabetes and chronic obstructive pulmonary diseasePrim Care Diabetes20093314114819632167
   PubMed Web of Science ®Google Scholar
• JonesPWBrusselleGDal NegroRWHealth-related quality of life in patients by COPD severity within primary care in EuropeRespir Med20111051576620932736
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
   PubMed Web of Science ®Google Scholar
• RodríguezLAWallanderMAMartín-MerinoEJohanssonSHeart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care studyRespir Med2010104111691169920483577
   PubMed Web of Science ®Google Scholar
• SchaneREWalterLCDinnoACovinskyKEWoodruffPGPrevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary diseaseJ Gen Intern Med200823111757176218690488
   PubMed Web of Science ®Google Scholar
• SchnellKWeissCOLeeTThe prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008BMC Pulm Med2012122622695054
   PubMed Web of Science ®Google Scholar
• SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
   PubMed Web of Science ®Google Scholar
• SundhJStallbergBLisspersKMontgomerySMJansonCCo-morbidity, body mass index and quality of life in COPD using the Clinical COPD QuestionnaireCOPD20118317318121513436
   PubMedGoogle Scholar
• WalkerSFingletonJWeatherallMBeasleyRLimited generalisability of UPLIFT findings to clinical practiceThorax201368111066106723744029
   PubMed Web of Science ®Google Scholar
• PatelARHurstJRExtrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the artExpert Rev Respir Med20115564766221955235
   PubMed Web of Science ®Google Scholar
• VerhammeKMvan BlijderveenNSturkenboomMCTiotropium and the risk of death in COPDN Engl J Med2014370548148224476443
   PubMed Web of Science ®Google Scholar
• MathioudakisAGChatzimavridou-GrigoriadouVEvangelopoulouEMathioudakisGASiafakasNMComparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: are they equivalent?Pulm Pharmacol Ther2014282919724846455
   PubMed Web of Science ®Google Scholar
• TashkinDMetzdorfNHallmanCKöenen-BergmannMKupasKDahlRSafety of Tiotropium in Renally Impaired PatientsPresented at the European Respiratory Society (ERS) Congress 2014. Abstract P-923MunichERS2014 Available from: www.boehringer-ingelheim.com/content/dam/internet/opu/com_EN/document/05_clinical_trials/qrcode/ers_2014/tashkin.pdfAccessed August 29, 2014
   Google Scholar